JP2015523963A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523963A5 JP2015523963A5 JP2015511433A JP2015511433A JP2015523963A5 JP 2015523963 A5 JP2015523963 A5 JP 2015523963A5 JP 2015511433 A JP2015511433 A JP 2015511433A JP 2015511433 A JP2015511433 A JP 2015511433A JP 2015523963 A5 JP2015523963 A5 JP 2015523963A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancer
- composition according
- effective amount
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/466,827 US8841350B2 (en) | 2011-05-11 | 2012-05-08 | Method for inducing UDP-glucuronosyltransferase activity using pterostilbene |
| US13/466,827 | 2012-05-08 | ||
| PCT/US2012/064993 WO2013169291A2 (en) | 2012-05-08 | 2012-11-14 | Method for inducing udp-glucuronosyltransferase activity using pterostilbene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015523963A JP2015523963A (ja) | 2015-08-20 |
| JP2015523963A5 true JP2015523963A5 (enExample) | 2015-10-29 |
Family
ID=47142275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511433A Pending JP2015523963A (ja) | 2012-05-08 | 2012-11-14 | プテロスチルベンを使用してｕｄｐ−グルクロノシルトランスフェラーゼ活性を誘導する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8841350B2 (enExample) |
| EP (1) | EP2846785A4 (enExample) |
| JP (1) | JP2015523963A (enExample) |
| KR (1) | KR20150027081A (enExample) |
| CN (1) | CN104768543A (enExample) |
| AU (1) | AU2012379655B2 (enExample) |
| BR (1) | BR112014027646A2 (enExample) |
| CA (1) | CA2872623A1 (enExample) |
| IN (1) | IN2014DN09990A (enExample) |
| MX (1) | MX2014013503A (enExample) |
| WO (1) | WO2013169291A2 (enExample) |
| ZA (1) | ZA201408893B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160067193A1 (en) * | 2014-09-04 | 2016-03-10 | The Regents Of The University Of California | Topical pterostilbene compositions for use in treating uv-induced skin damage and hyperplasia |
| EP3194032B1 (en) * | 2014-09-04 | 2021-06-23 | The Regents of the University of California | Topical pterostilbene compositions for use in treating loss of barrier function in skin in burn injurys |
| WO2016200447A1 (en) * | 2015-06-10 | 2016-12-15 | Elysium Health, Inc. | Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders |
| US12134956B2 (en) | 2022-10-11 | 2024-11-05 | Halliburton Energy Services, Inc. | Liner hanger system |
| US12398624B2 (en) | 2023-07-11 | 2025-08-26 | Halliburton Energy Services, Inc. | Self-energizing seal for expandable liner hanger |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6623724B2 (en) * | 1996-09-18 | 2003-09-23 | Applied Genetics Incorporated Dermatics | Dermatological compositions and methods |
| US6414037B1 (en) * | 1998-01-09 | 2002-07-02 | Pharmascience | Pharmaceutical formulations of resveratrol and methods of use thereof |
| DE10161253A1 (de) | 2001-12-13 | 2003-06-26 | Dragoco Gerberding Co Ag | Verwendung von Dihydropinosylvin und dessen Derivaten als Inhibitoren |
| FR2869229B1 (fr) | 2004-04-26 | 2006-08-25 | Sederma Soc Par Actions Simpli | Utilisation d'un inducteur des ugt par voie topique |
| ES2246165B1 (es) | 2004-07-20 | 2006-12-01 | Universitat De Valencia | Uso combinado del pteroestilbeno y la quercetina para la fabricacion de medicamentos utiles en el tratamiento del cancer. |
| US8426369B2 (en) | 2006-12-07 | 2013-04-23 | Rutgers, The State University Of New Jersey | Prevention and treatment of colon cancer |
| US8509879B2 (en) | 2007-11-06 | 2013-08-13 | The Regents Of The University Of California | Apparatus and method for widefield functional imaging (WiFI) using integrated structured illumination and laser speckle imaging |
| AU2009204181A1 (en) * | 2008-01-08 | 2009-07-16 | David Rubin | Method and compositions for administering resveratrol and pterostilbene |
| US20090324740A1 (en) | 2008-06-13 | 2009-12-31 | Albritton Iv Ford D | Novel nasal spray |
| US20100240767A1 (en) | 2009-03-23 | 2010-09-23 | Muhammed Majeed | Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof |
| US9737495B2 (en) | 2009-06-22 | 2017-08-22 | Indus Biotech Private Limited | Process for obtaining purified pterostilbene and methods of use thereof |
| US20110136751A1 (en) | 2009-10-06 | 2011-06-09 | Green Molecular | Use of Polyphenols in the Treatment of Cancer |
| EP2322159A1 (en) | 2009-10-30 | 2011-05-18 | Green Molecular, S.L. | Use of pterostilbene (pter) as medicament for prevention and/or treatment of skin diseases, damages or injures or as cosmetic |
| US8399712B2 (en) * | 2010-02-03 | 2013-03-19 | Laurus Labs Private Limited | Pterostilbene cocrystals |
| US8883218B2 (en) * | 2010-03-26 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Anti-cancer nanoparticle compositions and methods of use |
| CN110015962B (zh) | 2011-01-28 | 2022-03-15 | 肯塔基大学研究基金会 | 茋类似物和治疗癌症的方法 |
| WO2013051459A1 (ja) * | 2011-10-02 | 2013-04-11 | キユーピー 株式会社 | ＲＮＡ干渉によるｍＲＮＡ発現の抑制を促進する促進剤およびその用途 |
-
2012
- 2012-05-08 US US13/466,827 patent/US8841350B2/en active Active - Reinstated
- 2012-11-14 IN IN9990DEN2014 patent/IN2014DN09990A/en unknown
- 2012-11-14 JP JP2015511433A patent/JP2015523963A/ja active Pending
- 2012-11-14 KR KR20147034337A patent/KR20150027081A/ko not_active Withdrawn
- 2012-11-14 CN CN201280074486.2A patent/CN104768543A/zh active Pending
- 2012-11-14 CA CA2872623A patent/CA2872623A1/en not_active Abandoned
- 2012-11-14 MX MX2014013503A patent/MX2014013503A/es unknown
- 2012-11-14 EP EP12876092.3A patent/EP2846785A4/en not_active Withdrawn
- 2012-11-14 AU AU2012379655A patent/AU2012379655B2/en not_active Expired - Fee Related
- 2012-11-14 WO PCT/US2012/064993 patent/WO2013169291A2/en not_active Ceased
- 2012-11-14 BR BR112014027646A patent/BR112014027646A2/pt not_active IP Right Cessation
-
2014
- 2014-09-22 US US14/493,058 patent/US10039725B2/en active Active - Reinstated
- 2014-12-04 ZA ZA2014/08893A patent/ZA201408893B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015523963A5 (enExample) | ||
| GEP201706678B (en) | Method of treating cancer and bone cancer | |
| SG194447A1 (en) | Aryl-or heteroaryl-substituted benzene compounds | |
| BR112016011078A8 (pt) | derivados de 1-(5-terc-butil-2-arilpirazol-3-il)-3-[2-flúor-4-[(3-oxo-4h-pirido[2,3-b]pirazin-8- il)óxi]fenil]ureia, seus usos, sua composição farmacêutica, método para preparar a mesma e método in vitro para inibir a função raf em uma célula | |
| RU2013131004A (ru) | Комбинация (а) ингибитора фосфоинозит-3-киназы и (б) модулятора пути ras/raf/mek | |
| MX2009013815A (es) | Compuestos de quinazolinona y metodos de uso para los mismos. | |
| MX377157B (es) | Preparación para usarse en el tratamiento de un cáncer positivo de gd2. | |
| NZ700881A (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
| RU2015121367A (ru) | Фармацевтическая комбинация, содержащая ингибитор b-raf и ингибитор деацетилазы гистонов, и ее применение при лечении пролиферативных заболеваний | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| BR112015027400A2 (pt) | Anticorpos capazes de se ligar especificamente ao her2 | |
| WO2016051398A8 (en) | Patient-specific immunotherapy for treating heterogeneous tumors | |
| IN2014DN09228A (enExample) | ||
| JP2014509653A5 (enExample) | ||
| BR102012006063A8 (pt) | Inibidor de met para uso no tratamento de um paciente sofrendo de um tumor, e, sequência de nucleotídeo | |
| RU2015152785A (ru) | Лечение злокачественной опухоли налтрексоном | |
| JP2013544892A5 (enExample) | ||
| JP2014530181A5 (enExample) | ||
| JP2015527374A5 (enExample) | ||
| WO2012142615A3 (en) | Auranofin and auranofin analogs useful to treat proliferative disease and disorders | |
| EA201690321A1 (ru) | Применение иммуноконъюгата антитела к muc1 и майтанзиноида для лечения солидных опухолей | |
| JP2015507020A5 (enExample) | ||
| MX2011008994A (es) | Metodos de usar sns - 595 para el tratamiento de sujetos con cancer con actividad reducida de brca2. | |
| JP2017525738A5 (enExample) | ||
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. |